Navigation Links
FDA Appoints Highly Qualified Scientific Experts to Tobacco Products Scientific Advisory Committee

WASHINGTON, March 1 /PRNewswire-USNewswire/ -- The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids:

(Logo: )

The U.S. Food and Drug Administration today has taken another critical step in implementing its new authority to regulate tobacco products by appointing a group of highly qualified scientists and health professionals to its Tobacco Products Scientific Advisory Committee.  The panel appointed today includes some of the world's foremost scientific authorities on tobacco products and marketing.   They offer exactly the broad scientific expertise and strong commitment to public health needed to help the FDA succeed in reducing the death and disease caused by tobacco use.  The Scientific Advisory Committee will provide advice, information and recommendations to the FDA on a wide range of tobacco-related issues.

With the appointment of the Scientific Advisory Committee, the FDA continues to move quickly and aggressively to exercise its new authority to regulate tobacco products, including the Congressional mandate to examine and develop recommendations with regard to menthol.  President Obama last June signed into law the historic legislation giving the FDA this authority.  The FDA's rapid action indicates a strong commitment by the Obama Administration and the FDA to seize the historic opportunity presented by the new law to significantly reduce tobacco use, the number one cause of preventable death in the United States.  Tobacco use kills more than 400,000 Americans every year and costs the nation $96 billion annually in health care bills.

The roster of Scientific Advisory Committee members appointed today can be found at:

SOURCE Campaign for Tobacco-Free Kids

Back to top



SOURCE Campaign for Tobacco-Free Kids
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Yayi International Appoints New Chief Financial Officer
2. Quantum Health Appoints Stark as Executive Vice President of Sales
3. Cochlear Appoints Switched on Media to Develop its SEO Across the Asia Pacific Region
4. Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record
5. Ground Breaking Molecular Diagnostics Business Appoints New CEO
6. Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager
7. VSP Global Appoints New Chief Financial Officer
8. U.S. HealthWorks Appoints National Sales Director
9. Concordis Group, Inc. Appoints Head of Physician Advisory Council
10. Health Dimensions Group Appoints Mary Nell Zellner as Senior Vice President of Consulting
11. Enterhealth Appoints Dr. Carlos Tirado as Chief Medical Officer
Post Your Comments:
(Date:12/1/2015)... ... ... Hospital Tampa is the first health care provider in the region to offer the ... is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult ... least 40 to 45 kg, or a BMI of at least 35 to 39.9 kg ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Dr. Paul Vitenas, ... Cosmetic Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice ... best among the many elite aesthetic physicians honored by the industry publication. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Annual 2015 Golden Bridge Business Awards under the New Products and Services category ... web based sample management software that helps labs organize data and ...
(Date:12/1/2015)... ... 2015 , ... For many X-rays taken at hospitals, doctors’ ... by the radiologist. The marking utensils are so small, however, they are difficult ... way to alleviate this problem. , He developed the patent-pending MARK N SHOW ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been awarded a fixed price per sprint agile development contract to support ... $34 million over five years, provides software engineering, infrastructure, as well as operations ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® blood purification technology to reduce ... world, today announced that Dr. Phillip Chan ... to participate in the LD Micro Main Event ... Conference, both of which will be held in ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology: